Blood-filtering Cancer Treatments
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
194
NCT04004910
A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 31, 2019
Completion: Jul 31, 2023
NCT04690686
Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).
Phase: Phase 2
Start: Oct 1, 2020
Completion: Dec 31, 2022
Loading map...